Cargando…
Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells
The αVβ6 integrin, an epithelial-specific cell surface receptor absent in normal prostate and expressed during prostate cancer (PrCa) progression, is a therapeutic target in many cancers. Here, we report that transcript levels of ITGB6 (encoding the β6 integrin subunit) are significantly increased i...
Autores principales: | Krishn, Shiv Ram, Garcia, Vaughn, Naranjo, Nicole M., Quaglia, Fabio, Shields, Christopher D., Harris, Maisha A., Kossenkov, Andrew V., Liu, Qin, Corey, Eva, Altieri, Dario C., Languino, Lucia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865252/ https://www.ncbi.nlm.nih.gov/pubmed/35188070 http://dx.doi.org/10.1080/15384047.2022.2030622 |
Ejemplares similares
-
Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression
por: Quaglia, Fabio, et al.
Publicado: (2021) -
The αvβ6 integrin in cancer cell-derived small extracellular vesicles enhances angiogenesis
por: Krishn, Shiv Ram, et al.
Publicado: (2020) -
Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells
por: Quaglia, Fabio, et al.
Publicado: (2020) -
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer
por: Quaglia, Fabio, et al.
Publicado: (2022) -
Tumor-Derived Extracellular Vesicles Require β1 Integrins to Promote Anchorage-Independent Growth
por: DeRita, Rachel M., et al.
Publicado: (2019)